Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 34
Filtrer
1.
Soins Psychiatr ; (277): 35-9, 2011.
Article de Français | MEDLINE | ID: mdl-22165334

RÉSUMÉ

The mechanism of addiction can be compared to a rut in a road, towards which patients are attracted and into which they inevitably fall. The role of the nurse in addictology is to lead the patient to consider other roads, to tread a new path taking them in a more positive direction. It is on this condition that programmes based on substitution can prove effective.


Sujet(s)
Métaphore , Rôle de l'infirmier , Troubles liés à une substance/soins infirmiers , France , Humains , Stupéfiants/usage thérapeutique , Relations infirmier-patient , Troubles liés aux opiacés/soins infirmiers , Syndrome de sevrage/soins infirmiers
2.
Curr Pharm Des ; 17(14): 1410-5, 2011.
Article de Anglais | MEDLINE | ID: mdl-21524260

RÉSUMÉ

Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuous process involving different neurobiological pathways, depending on the stage of addiction. A specific emphasis will be made on the development of dysfunctional automatic behaviors in late stage of addiction and the central role of glutamate and AMPA receptors. The aim is to propose that if a too broad effect of anti-addiction medication is expected (such as anti-craving, anti-relapse and preventive effects), the results might be disappointing. The speculative specific efficacy of topiramate in addiction is described.


Sujet(s)
Systèmes de délivrance de médicaments , Fructose/analogues et dérivés , Troubles liés à une substance/traitement médicamenteux , Comportement toxicomaniaque/traitement médicamenteux , Fructose/pharmacologie , Fructose/usage thérapeutique , Acide glutamique/métabolisme , Humains , Modèles biologiques , Neuroprotecteurs/pharmacologie , Neuroprotecteurs/usage thérapeutique , Récepteur de l'AMPA/métabolisme , Prévention secondaire , Topiramate
4.
J Psychoactive Drugs ; 41(1): 1-10, 2009 Mar.
Article de Anglais | MEDLINE | ID: mdl-19455904

RÉSUMÉ

The khat plant contains psychoactive alkaloids with psychostimulant properties, and has been used for centuries as a recreational and religious drug, mainly in some African and Middle Eastern countries. With changing migration patterns, epidemiological and clinical outcomes may have changed. The aim of this article is to review current knowledge on pharmacological, epidemiological and clinical aspects of khat use. Khat use is still highly prevalent in the countries mentioned, and in African and Yemeni emigrant groups. Preclinical and clinical data confirm its addictive potential as well as possible psychological, psychiatric and medical consequences related to stimulant use; however, existing epidemiological studies do not focus on the prevalence of problematic use or dependence. There are no indications of high prevalence of khat use in other cultural and ethnic groups. Data are lacking on possible increased psychotogenic risks when khat is used outside of the original cultural context. As with alcohol use in many countries, khat use can be considered as a lifestyle in some specific countries, covering the spectrum from nonproblematic use to problematic use and dependence. Khat dependence is associated with high morbidity and societal and economical costs.


Sujet(s)
Catha , Usagers de drogues , Mode de vie , Psychoanaleptiques/effets indésirables , Troubles liés à une substance/épidémiologie , Afrique/épidémiologie , Animaux , Catha/composition chimique , Système nerveux central/effets des médicaments et des substances chimiques , Caractéristiques culturelles , Usagers de drogues/psychologie , Émigration et immigration , Humains , Moyen Orient/épidémiologie , Feuilles de plante , Préparations à base de plantes/effets indésirables , Prévalence , Psychoanaleptiques/économie , Psychoanaleptiques/isolement et purification , Comportement social , Facteurs socioéconomiques , Troubles liés à une substance/économie , Troubles liés à une substance/ethnologie , Troubles liés à une substance/psychologie
6.
Acta Medica (Hradec Kralove) ; 51(1): 19-24, 2008.
Article de Anglais | MEDLINE | ID: mdl-18683665

RÉSUMÉ

UNLABELLED: While antidepressant prescription rules are established for approved indications by large-scale studies, off-label utilization naturally often lacks the validation by large scientific databases, and is at its best based on expert consensus. The aim of the present survey was to study the prescription habits of hospital psychiatrists with regard to antidepressants, comparing patients treated for depressions and anxiety disorder with patients receiving off-label antidepressant treatment. METHODS: Data on drug use for this study were based on 6 reference days from April 1999 to November 2001 in the 98-bed psychiatric hospital of the University of Lausanne, Switzerland. The drug prescriptions of 174 patients were assessed. RESULTS: Whereas the diagnosis did not influence the choice between newer or older antidepressants, patients presenting an anxiety disorder were 4.5 times more likely (p<0.05) and patients with other diagnoses 8 times more likely (p<0.001) to receive an antipsychotic comedication compared to patients whose primary diagnosis was a depressive disorder. Also, patients receiving concomitantly a nonbenzodiazepine hypnotic were less likely to be prescribed an older antidepressant (p<0.05). While patients with anxiety disorder and those with major depression received their antidepressants at comparable doses, patients with an off-label indication were treated preferentially with lower doses. CONCLUSIONS: The results of this survey suggest, that the prescribing hospital psychiatrists developed preferences with regard to the choice of the antidepressant class, which they then used for both registered and off-label indications. They then seemed to adapt the dose and the comedication according to the diagnosis, confirming the initial study hypothesis.


Sujet(s)
Antidépresseurs/usage thérapeutique , Adulte , Sujet âgé , Troubles anxieux/traitement médicamenteux , Trouble dépressif/traitement médicamenteux , Utilisation médicament , Femelle , Hôpitaux psychiatriques , Humains , Mâle , Adulte d'âge moyen , Psychiatrie
7.
Psychiatr Q ; 79(4): 301-9, 2008 Dec.
Article de Anglais | MEDLINE | ID: mdl-18756354

RÉSUMÉ

BACKGROUND: Internet is commonly used by the general population, notably for health information-seeking. There has been little research into its use by patients treated for a psychiatric disorder. AIM: To evaluate the use of internet by patients with psychiatric disorders in searching for general and medical information. METHODS: In 2007, 319 patients followed in a university hospital psychiatric out-patient clinic, completed a 28-items self-administered questionnaire. RESULTS: Two hundred patients surveyed were internet users. Most of them (68.5%) used internet in order to find health-related information. Only a small part of the patients knew and used criteria reflecting the quality of contents of the websites consulted. Knowledge of English and private Internet access were the factors significantly associated with the search of information on health on Internet. CONCLUSIONS: Internet is currently used by patients treated for psychiatric disorders, especially for medical seeking information.


Sujet(s)
Information en santé des consommateurs , Internet/statistiques et données numériques , Personnes atteintes de troubles mentaux , Accès à l'information , Adulte , Analyse statistique factorielle , Humains , Adulte d'âge moyen , Services de consultations externes des hôpitaux , Patients en consultation externe , Enquêtes et questionnaires
8.
Arch Psychiatr Nurs ; 22(1): 50-1, 2008 Feb.
Article de Anglais | MEDLINE | ID: mdl-18207056

RÉSUMÉ

Depressive states may at times be particularly tricky to ascertain or confirm during a time-limited consultation. For example, a patient may present with what has been termed as smiling depression. We present the case of a female patient with bipolar II disorder whose difficult-to-ascertain depression could be confirmed by her automatic wristwatch, which regularly stopped when she was hypokinetic as a result of her depression.


Sujet(s)
Activités de la vie quotidienne/psychologie , Trouble bipolaire , Évaluation des besoins en soins infirmiers/méthodes , Sourire/psychologie , Perception du temps , Attitude envers la santé , Trouble bipolaire/diagnostic , Trouble bipolaire/psychologie , Femelle , Humains , Adulte d'âge moyen , Soins infirmiers en psychiatrie , Auto-évaluation (psychologie)
9.
Community Ment Health J ; 44(2): 86-96, 2008 Apr.
Article de Anglais | MEDLINE | ID: mdl-17694435

RÉSUMÉ

The objective of this survey was to assess the beliefs of Swiss psychiatrists about the risks associated with cannabis, and to assess their prohibitive attitudes toward their patients. Eighty-two doctors agreed to fill-up the questionnaire. Cluster analysis retained a 3-cluster solution. Cluster 1: "Prohibitionists" believed that cannabis could induce and trigger all forms of psychiatric disorder, and showed a highly prohibitive attitude. Cluster 2: "Causalists" believed that schizophrenia, but not other psychiatric disorders, could be induced and triggered. Cluster 3: "Prudent liberals" did not believe that psychiatric disorders could be induced by cannabis, and were generally less prohibitive.


Sujet(s)
Attitude du personnel soignant , Cannabinoïdes/toxicité , Culture (sociologie) , Médecine factuelle , Abus de marijuana/complications , Troubles mentaux/induit chimiquement , Psychiatrie , Schizophrénie/induit chimiquement , Adulte , Troubles anxieux/induit chimiquement , Troubles anxieux/prévention et contrôle , Troubles anxieux/psychologie , Trouble bipolaire/induit chimiquement , Trouble bipolaire/prévention et contrôle , Trouble bipolaire/psychologie , Causalité , Trouble dépressif/induit chimiquement , Trouble dépressif/prévention et contrôle , Trouble dépressif/psychologie , Femelle , Enquêtes de santé , Humains , Mâle , Abus de marijuana/épidémiologie , Abus de marijuana/prévention et contrôle , Troubles mentaux/prévention et contrôle , Troubles mentaux/psychologie , Adulte d'âge moyen , Risque , Schizophrénie/diagnostic , Psychologie des schizophrènes , Enquêtes et questionnaires , Suisse
13.
Eur Addict Res ; 13(1): 20-4, 2007.
Article de Anglais | MEDLINE | ID: mdl-17172775

RÉSUMÉ

Slow downtitration as a methadone discontinuation method is time-consuming and associated to high dropout rates. Whereas ultra-rapid opiate detoxification methods have recently gained some popularity, they are expensive and may be associated with particular problems in methadone patients. In the present study, a 3-day detoxification procedure accelerated with a unique dose of naltrexone was used in 10 methadone-substituted patients. Whereas the treatment resulted in a shortened withdrawal syndrome, which was satisfactorily controlled by the drugs used, a two-phase course was observed, some symptoms reappearing between the end of day 2 and the beginning of day 3. The first phase of withdrawal symptoms was attributed to the antagonistic effect of naltrexone, which possibly also improved under the weakening of naltrexone. The second phase of withdrawal symptoms may be related to falling methadone plasma levels.


Sujet(s)
Dépendance à l'héroïne/rééducation et réadaptation , Méthadone/effets indésirables , Naltrexone/usage thérapeutique , Antagonistes narcotiques/usage thérapeutique , Stupéfiants/effets indésirables , Syndrome de sevrage/traitement médicamenteux , Syndrome de sevrage/étiologie , Adulte , Évaluation préclinique de médicament , Femelle , Humains , Mâle , Méthadone/usage thérapeutique , Stupéfiants/usage thérapeutique , Projets pilotes , Résultat thérapeutique
14.
Sante Ment Que ; 31(1): 125-43, 2006.
Article de Français | MEDLINE | ID: mdl-17111063

RÉSUMÉ

UNLABELLED: Bipolar disorder is a severe mood disorder characterized by recurrence of mania and depression. Despite the use of mood stabilizers, a significant proportion of bipolar patients experience relapse, psychosocial impairment and persistent symptoms. A significant part of patients show poor adhesion to the pharmacological treatment. This article aims to provide an overview of research focusing on psychoeducational and cognitive-behavioral treatment (CBT) of bipolar patients. METHOD: Studies were identified through Medline searches between 1971 and 2005. RESULTS: Studies on bipolar patients suggest that psychoeducational interventions may improve treatment adherence, illness knowledge, ability to cope with early manic symptoms and tend to reduce the risk of manic relapses. CBT tends to diminish depressive symptoms, improve treatment adherence and reduce the risk of depressive and manic relapses. Most psychoeducational and CBT studies share a common medical model of the illness, thereby making clear distinctions of impact of each intervention difficult. Few studies focused on patients with problems with mood stabilizers adherence. It is now important to develop specific interventions for those patients. CONCLUSION: According to these studies, bipolar patients are likely to benefit from psychoeducational or CBT interventions added to usual pharmacotherapy. In order to overcome limitations of existing research, future studies should adjust for the effect of pharmacological treatment, the type and severity of psychopathology at baseline, the acceptance of and the adaptability to the illness and it's awareness.


Sujet(s)
Trouble bipolaire/thérapie , Thérapie cognitive , Éducation du patient comme sujet , Adaptation psychologique , Anticonvulsivants/administration et posologie , Antimaniacodépressifs/administration et posologie , Conscience immédiate , Trouble bipolaire/diagnostic , Trouble bipolaire/psychologie , Humains , Observance par le patient/psychologie , Prévention secondaire , Rôle de malade
15.
Bipolar Disord ; 8(4): 415-7, 2006 Aug.
Article de Anglais | MEDLINE | ID: mdl-16879143

RÉSUMÉ

The case of a bipolar patient with concomitant multidrug addiction is described who presented a decrease in valproate plasma level of more than 50% shortly after antiretroviral therapy was initiated. Despite important dose augmentations of up to 4 g/day, plasma levels were difficult to raise to the target concentration of 50 mg/dL. The possible mechanisms underlying the observed pharmacokinetic changes are discussed: (i) a uridine diphosphate-glucuronosyl transferase induction by efavirenz; and (ii) a plasma protein displacement of valproate by efavirenz with subsequent increased elimination of the free fraction.


Sujet(s)
Agents antiVIH/pharmacologie , Anticonvulsivants/sang , Trouble bipolaire/sang , Oxazines/pharmacologie , Acide valproïque/sang , Adulte , Alcynes , Agents antiVIH/usage thérapeutique , Anticonvulsivants/usage thérapeutique , Benzoxazines , Trouble bipolaire/complications , Trouble bipolaire/virologie , Cyclopropanes , Relation dose-effet des médicaments , Interactions médicamenteuses , Association de médicaments , Infections à VIH/sang , Infections à VIH/complications , Infections à VIH/traitement médicamenteux , Humains , Mâle , Oxazines/usage thérapeutique , Troubles liés à une substance/sang , Troubles liés à une substance/complications , Troubles liés à une substance/virologie , Acide valproïque/usage thérapeutique
16.
BMC Psychiatry ; 6: 22, 2006 May 23.
Article de Anglais | MEDLINE | ID: mdl-16719909

RÉSUMÉ

BACKGROUND: Among the multiple mechanisms of action of topiramate, AMPA/kainate antagonism may be particularly interesting for the treatment of disorders characterized by conditioned cognitive and behavioral cue reactivity. CASE PRESENTATION: We report the case of a patient consulting primarily for obesity and cue triggered snacking, who responded well on topiramate at doses up to 50 mg. Coincidentally he reported on an improvement of compulsive nonparaphilic sexual behaviors (consumption of prostitution), which was also strongly triggered by environmental cues. Both addictive behaviors (snacking and consumption of prostitution) reoccurred after discontinuation of topiramate and again responded reintroduction of the drug. CONCLUSION: The present case report of topiramate's effect on comorbid obesity and nonparaphilic addiction could be interpreted as a further indication that topiramate acts on the common pathway underlying conditioned behaviors and seems to be a treatment of behavioral disorders associated with environmental cues.


Sujet(s)
Agents antiobésité/usage thérapeutique , Comportement toxicomaniaque/traitement médicamenteux , Comportement compulsif/traitement médicamenteux , Fructose/analogues et dérivés , Obésité/traitement médicamenteux , Comportement sexuel/effets des médicaments et des substances chimiques , Adulte , Agents antiobésité/pharmacologie , Comportement toxicomaniaque/épidémiologie , Comportement toxicomaniaque/psychologie , Comorbidité , Comportement compulsif/psychologie , Conditionnement psychologique/effets des médicaments et des substances chimiques , Conditionnement psychologique/physiologie , Signaux , Consommation alimentaire/effets des médicaments et des substances chimiques , Consommation alimentaire/psychologie , Fructose/pharmacologie , Fructose/usage thérapeutique , Humains , Mâle , Obésité/épidémiologie , Obésité/psychologie , Récepteur de l'AMPA/physiologie , Récepteurs kaïnate/effets des médicaments et des substances chimiques , Récepteurs kaïnate/physiologie , Récidive , Prostitution/psychologie , Comportement sexuel/psychologie , Topiramate , Résultat thérapeutique
17.
Acta Medica (Hradec Kralove) ; 49(1): 75-6, 2006.
Article de Anglais | MEDLINE | ID: mdl-16696448

RÉSUMÉ

The case of a 56 years old man is presented, who developed acute generalized exanthematous pustulosis 5 days after the introduction of olanzapine 10 mg. Multiple 1-mm pustules appeared on the whole body, concentrated especially on her neck and face. Within 2 days, the eruption was increasingly accompanied by erythema and pruritus. No fever, chills, nausea, vomiting, arthralgias or myalgias were recorded. The diagnosis was corroborated by hystopathology. After 7 days of treatment, olanzapine and valproate were stopped. Concomitantly, cetirizine 20 mg p.o. and methylprednisolone 500 mg i.v. were given once. During the following week betamethasone cream was applied, and the pustular eruption resolved completely.


Sujet(s)
Neuroleptiques/effets indésirables , Toxidermies/étiologie , Exanthème/induit chimiquement , Dermatoses vésiculobulleuses/induit chimiquement , Maladie aigüe , Benzodiazépines/effets indésirables , Toxidermies/traitement médicamenteux , Toxidermies/anatomopathologie , Exanthème/traitement médicamenteux , Exanthème/anatomopathologie , Femelle , Humains , Adulte d'âge moyen , Olanzapine , Dermatoses vésiculobulleuses/traitement médicamenteux , Dermatoses vésiculobulleuses/anatomopathologie
18.
Psychiatry Clin Neurosci ; 60(3): 384-8, 2006 Jun.
Article de Anglais | MEDLINE | ID: mdl-16732758

RÉSUMÉ

Due to its AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)/kainate antagonism, topiramate would be particularly interesting in addiction treatment. Flexible-dose topiramate was prescribed to 13 smokers (10 smokers who wanted to stop smoking, and three who received topiramate for other reasons). Six out of 13 smokers were abstinent at 2 months and two more subjects had reduced their cigarette consumption by >50%. With one exception, temporary reduction of the number of smoked cigarettes preceded definitive abstinence at month 2. Three more subjects who achieved a momentary reduction had, however, to interrupt the treatment due to intolerable side-effects. Controlled trials are needed to confirm these preliminary observations.


Sujet(s)
Comportement toxicomaniaque/traitement médicamenteux , Fructose/analogues et dérivés , Neuroprotecteurs/usage thérapeutique , Arrêter de fumer , Prévention du fait de fumer , Adulte , Femelle , Fructose/usage thérapeutique , Humains , Mâle , Adulte d'âge moyen , Projets pilotes , Récepteur de l'AMPA , Topiramate , AMPA/agonistes
20.
Prog Neuropsychopharmacol Biol Psychiatry ; 30(7): 1350-2, 2006 Sep 30.
Article de Anglais | MEDLINE | ID: mdl-16630677

RÉSUMÉ

There is data supporting the hypothesis that the endogenous opioid system may play a role in the pathophysiology of Obsessive Compulsive Disorder (OCD). The authors report a case of worsening of OCD during methadone tapering, which seems to confirm the role of the opioid system in the pathophysiology of OCD. The possible involvement of the cortico-limbic-basal-ganglia-thalamic circuit in the observed phenomenon is discussed.


Sujet(s)
Méthadone , Stupéfiants , Trouble obsessionnel compulsif/rééducation et réadaptation , Adulte , Contre-indications , Humains , Mâle
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE